论文部分内容阅读
自1981年11月～1984年1月共收治199例流行性出血热(EHF)患者,对其可溶性免疫复合物进行检测,现报告如下。 1 临床资料 1.1 一般资料:199例中男性146例,女性53例。年龄最小8岁,最大64岁,其中20～50岁148例,占71.9％ 1.2 临床分型:本文病例的诊断、分型均以1987年全国流行性出血热防治(试行)方案为依据。轻型59例,中型110例,重型21例,危重型9例。 1.3 住院天数:轻型平均9.2天,中型平均9.8天,重型平均12.4天,危重型平均21天。 1.4 可溶性免疫复合物(CIC)检测方法:
A total of 199 patients with epidemic hemorrhagic fever (EHF) were enrolled from November 1981 to January 1984 and their soluble immune complexes were detected. The results are reported as follows. 1 Clinical data 1.1 General information: 199 cases of 146 males and 53 females. The youngest 8 years old, maximum 64 years old, of which 148 cases of 20 to 50 years old, accounting for 71.9% 1.2 Clinical classification: The diagnosis of this case, classification were based on the 1987 National Epidemic Hemorrhagic Fever (Trial) program as the basis. 59 were light, 110 were medium, 21 were heavy and 9 were critically ill. 1.3 days of hospital stay: light average of 9.2 days, medium average of 9.8 days, heavy average of 12.4 days, critically ill average of 21 days. 1.4 soluble immune complexes (CIC) detection methods: